Parallel Advisors’s DarioHealth DRIO Stock Holding History

Parallel Advisors’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	-$1K	–	2959
2021 Q1	$1K	Buy	+3	New	+$1.35K	﹤0.01%	2601

Other funds holding DRIO

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Fidelity International

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Parallel Advisors's DRIO Position: Q2 2021 in Review

Parallel Advisors sold out of DarioHealth (DRIO) in Q2 2021, closing a stake of 3 shares — an estimated $1K sold.

Parallel Advisors first reported a position in DRIO in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2021.

Parallel Advisors reported no remaining DarioHealth position as of Q2 2021 after selling out during the quarter.
Parallel Advisors sold 3 DarioHealth shares in Q2 2021, an estimated $1K.
Parallel Advisors first reported a position in DarioHealth in Q1 2021 and held it in 1 quarter.
Parallel Advisors's DarioHealth position peaked at $1K in Q1 2021.
58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2021.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.